# Neurelis (United States) > organization **Wikidata**: [Q100956338](https://www.wikidata.org/wiki/Q100956338) **Source**: https://4ort.xyz/entity/neurelis-united-states ## Summary Neurelis is a United States-based business organization founded in 2007 and headquartered in San Diego, California. The company operates as a commercial entity engaged in professional activities within the biotechnology or pharmaceutical sector, as evidenced by its presence in research organization databases and its website focused on technologies. Neurelis is classified as a business organization and is indexed in major research infrastructure identifiers including the Research Organization Registry (ROR) and the Grid database of scientific institutions. ## Key Facts - **Official Name:** Neurelis - **Country:** United States - **Inception:** 2007 - **Headquarters Location:** San Diego, California, USA (coordinates: 33.02054° N, 117.077157° W) - **Classification:** Business (organization undertaking commercial, industrial, or professional activity) - **Website:** https://www.neurelis.com/our-technologies - **ROR ID:** 0358t2s53 - **GRID ID:** grid.508865.6 - **Wikidata Description:** Organization ## FAQs **What type of organization is Neurelis?** Neurelis is classified as a business organization, which is defined as an entity engaged in commercial, industrial, or professional activities. It is legally considered a juridical person and operates with the goal of generating economic value. The business is specifically categorized as an instance of "business" within knowledge classification systems. **Where is Neurelis located?** Neurelis is headquartered in San Diego, California, United States. The specific headquarters coordinates are 33.02054° north latitude and 117.077157° west longitude. San Diego is a major city on the Pacific coast of Southern California, known for its biotechnology and pharmaceutical industry cluster. **When was Neurelis founded?** Neurelis was founded in 2007, making it a business that has been operating for over 15 years. The company was established during a period of growth in the biotechnology sector in San Diego, which is home to numerous biotech and life sciences companies. **How is Neurelis identified in research databases?** Neurelis is indexed in multiple major research and organizational databases. It has a Research Organization Registry (ROR) ID of 0358t2s53 and a GRID ID of grid.508865.6. These identifiers are used to uniquely identify research organizations in global knowledge graphs and academic databases. **What does Neurelis do?** Based on its website URL (neurelis.com/our-technologies), Neurelis appears to be a company focused on developing technologies, likely within the biotechnology or pharmaceutical sector. San Diego is renowned for its biotech industry, often referred to as "Biotech Beach," and Neurelis contributes to this ecosystem as a technology-focused business. ## Why It Matters Neurelis matters as part of San Diego's thriving biotechnology and life sciences cluster, which represents one of the major biotech hubs in the United States. The company's presence contributes to the region's economic ecosystem, job creation, and innovation in technology development. As a business founded in 2007, Neurelis has navigated the evolution of the biotech industry through periods of growth, economic challenges, and technological advancement. The company's classification as a business organization places it within the fundamental structure of economic activity in the United States. Businesses like Neurelis serve as the primary units of economic organization, mobilizing human capital, property, and enterprise to create value and potentially generate profit. In the context of the biotechnology sector, such organizations play a critical role in medical innovation, healthcare advancement, and economic development. San Diego's biotechnology industry is a significant contributor to California's economy and represents a major center for research and development in life sciences. Companies like Neurelis contribute to this ecosystem by participating in the broader network of academic institutions, research facilities, and commercial enterprises that characterize the region's innovation infrastructure. ## Notable For - **San Diego Biotech Presence:** Operating within one of the United States' major biotechnology hubs, often called "Biotech Beach" - **Research Database Inclusion:** Indexed in the Research Organization Registry (ROR) and GRID database, connecting it to global scientific infrastructure - **Technology Focus:** Dedicated website section for "our-technologies" indicating active technology development - **Established History:** Operating since 2007, demonstrating business longevity in a competitive industry - **Geographic Precision:** Headquarters location precisely documented with geographic coordinates ## Body ### Classification and Legal Status Neurelis is classified as a business organization, which in knowledge classification systems is defined as an organization undertaking commercial, industrial, or professional activities. This classification places Neurelis within the broader category of economic entities that are legally considered juridical persons. As a business, it operates as a structured entity with the organizational characteristics typical of commercial enterprises engaged in technology development and commercialization. The business classification system distinguishes between various types of organizations, and Neurelis falls specifically under the category of commercial businesses engaged in professional activities. This classification is significant for regulatory, taxation, and legal purposes within the United States business framework. ### Geographic Location and Headquarters Neurelis is headquartered in San Diego, California, a major metropolitan area on the Pacific coast of the United States. The precise headquarters coordinates are 33.02054° north latitude and 117.077157° west longitude, placing the organization in the southern region of San Diego County. This location is significant because San Diego has developed into a major center for biotechnology and life sciences research, often compared to the Boston-Cambridge biotech cluster on the East Coast. The city's biotechnology ecosystem includes numerous pharmaceutical companies, research institutions, and academic facilities, particularly associated with the University of California, San Diego. This geographic concentration provides Neurelis with access to talent, research collaborations, and the broader innovation infrastructure that characterizes the region. ### Historical Context and Founding Neurelis was founded in 2007, entering the business landscape during a period of significant activity in the biotechnology sector. The company's inception in 2007 placed it at the tail end of a major growth period in the biotech industry, just before the 2008 financial crisis that affected many sectors including life sciences. The company's survival and continued operation through various economic cycles demonstrates a degree of resilience and adaptability. The 2007 founding date also positions Neurelis within the era of modern biotechnology expansion, when advances in genomics, personalized medicine, and drug delivery technologies were creating new opportunities for companies in this space. ### Research Infrastructure and Identifiers Neurelis is indexed in several major research organization databases, which serve as critical infrastructure for the global research ecosystem. The company has been assigned a Research Organization Registry (ROR) ID of 0358t2s53. ROR is a community-driven identifier system that provides unique, persistent identifiers for research organizations, enabling better disambiguation and linking across scholarly infrastructure. Additionally, Neurelis has a GRID ID of grid.508865.6. The GRID (Global Research Identifier Database) database provides detailed information about research organizations globally, including their relationships to other entities, publications, and research activities. These identifiers connect Neurelis to the broader ecosystem of research organizations worldwide and facilitate academic and commercial collaborations. ### Digital Presence and Technology Focus Neurelis maintains an active digital presence through its website at https://www.neurelis.com/our-technologies. The specific focus on a "technologies" section suggests that the company is engaged in developing or commercializing technological solutions, likely within the biotechnology or pharmaceutical domain. This digital presence serves as a primary interface for potential partners, investors, and stakeholders to learn about the company's offerings and capabilities. The website domain and structure indicate a professional approach to business communication and marketing, typical of established technology companies in the United States. ### Relationship to Business Classification As a business organization, Neurelis embodies the characteristics defined in knowledge classification systems. A business is typically characterized by its goal-oriented nature, with the primary objective often being the generation of profit or economic value. Businesses consist of key components including the enterprise itself, economic activity, the business sector, property, and human capital. Neurelis operates within the broader category of businesses that are engaged in commercial, industrial, or professional activities. This classification encompasses a wide range of organizational types, from small sole proprietorships to large multinational corporations. The classification system recognizes businesses as distinct from other organizational types such as governmental entities, non-profit organizations, or educational institutions. ### San Diego Economic Context The presence of Neurelis in San Diego places it within one of the United States' most significant biotechnology clusters. San Diego's life sciences industry has grown substantially since the 1970s and 1980s, building on the presence of Scripps Research Institute, the University of California San Diego, and numerous pharmaceutical and biotechnology companies. The region's ecosystem includes major pharmaceutical companies, emerging biotech firms, research hospitals, and academic institutions. This concentration creates opportunities for collaboration, talent acquisition, and knowledge sharing that benefit companies like Neurelis operating within the cluster. San Diego's economic profile extends beyond biotechnology to include defense, tourism, and technology sectors, providing a diverse economic environment for businesses operating in the region. The city's proximity to Mexico also creates opportunities for cross-border collaboration and trade, though this aspect is less directly relevant to Neurelis's apparent focus on technology development. ## References 1. GRID release 2020-10-06 2. ROR Data Dump 6.0 (October 2020)